Fedenia Advisers LLC Astrazeneca PLC Transaction History
Fedenia Advisers LLC
- $252 Billion
- Q3 2025
A detailed history of Fedenia Advisers LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Fedenia Advisers LLC holds 5,886 shares of AZN stock, worth $526,208. This represents 0.18% of its overall portfolio holdings.
Number of Shares
5,886
Previous 4,604
27.85%
Holding current value
$526,208
Previous $322 Million
40.36%
% of portfolio
0.18%
Previous 0.15%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,541Shares Held
503MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...